|
Watzlawik, Jens O; Painter, Meghan M; Wootla, Bharath et al. (2015) A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients. J Nat Sci 1:
|
|
Paz Soldán, M Mateo; Novotna, Martina; Abou Zeid, Nuhad et al. (2015) Relapses and disability accumulation in progressive multiple sclerosis. Neurology 84:81-8
|
|
Painter, Meghan M; Morrison, James H; Zoecklein, Laurie J et al. (2015) Antiviral Protection via RdRP-Mediated Stable Activation of Innate Immunity. PLoS Pathog 11:e1005311
|
|
Perschbacher, Katherine; Smestad, John A; Peters, Justin P et al. (2015) Quantitative PCR analysis of DNA aptamer pharmacokinetics in mice. Nucleic Acid Ther 25:11-9
|
|
Wootla, Bharath; Denic, Aleksandar; Rodriguez, Moses (2014) Polyclonal and monoclonal antibodies in clinic. Methods Mol Biol 1060:79-110
|
|
Waubant, Emmanuelle; Mowry, Ellen M; Krupp, Lauren et al. (2013) Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Mult Scler 19:891-5
|
|
Tutuncu, Melih; Tang, Junger; Zeid, Nuhad Abou et al. (2013) Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler 19:188-98
|
|
Xu, Xiaohua; Denic, Aleksandar; Warrington, Arthur E et al. (2013) Therapeutics to promote CNS repair: a natural human neuron-binding IgM regulates membrane-raft dynamics and improves motility in a mouse model of multiple sclerosis. J Clin Immunol 33 Suppl 1:S50-6
|
|
Watzlawik, Jens O; Warrington, Arthur E; Rodriguez, Moses (2013) PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation. PLoS One 8:e55149
|
|
Nastasijevic, Branislav; Wright, Brent R; Smestad, John et al. (2012) Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis. PLoS One 7:e39595
|
Showing the most recent 10 out of 104 publications
